CAI logo

CARIS LIFE SCIENCES INC

CAINASDAQ
🏆 #954 by market capUS Equity
$397.80▼ $21.48 (−5.40%)
Simulated price
🔔
Track CAI
Get earnings, price moves & breaking news on Telegram
Track
24h▼ 5.4%
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$8.92B
Small Cap
📈Revenue Growth (YoY)
+38.5%
High Growth
📊Gross Margin
69.7%
High
💵FCF Margin
12.5%
Healthy
⚖️P/S Ratio
9.1x
Elevated
Otter Score
84
Good
No chart data available for CAI.

Trading Snapshot

Day Range
$396.52 – $404.10
52-Week Range
$14.19 – $33.66
Volume
$2.90B
Avg Volume
$2.86B
Shares Outstanding
282.7M
Next Earnings
Nov 28, 2026

Fundamentals Snapshot

Annual Revenue
$812M
Last Q Revenue
$264M
P/E Ratio
85.3
P/S Ratio
9.1x
EPS (TTM)
$0.37
Dividend Yield
—
Dilution (1yr)
+3.1%

Why Investors Own CAI

  • ✓High-growth profile — revenue up +54.7% YoY with expanding US Equity exposure.
  • ✓Healthy economics — 60% gross margin and 16% free-cash-flow margin.
  • ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

CAI logo

CARIS LIFE SCIENCES INC

CAI
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$812M▲ +97.0% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
66.4%▲ +53.1% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$45M▼ −117.5% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$67M▼ −126.4% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
289.9M▲ +3.1% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$419M▲ +$779M YoY
StockOtter · stockotter.space

About CARIS LIFE SCIENCES INC

Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing artificial intelligence to deliver comprehensive molecular profiling services to clients both in the United States and internationally. The company is dedicated to transforming medical care by innovating and bringing to market advanced solutions that leverage molecular data and sophisticated machine learning algorithms. Its extensive suite of molecular diagnostic offerings includes MI Profile, a specialized solution analyzing tissue samples, and Caris Assure, a blood-based test designed for cancer treatment applications. Furthermore, Caris provides research and development support to biopharmaceutical customers, encompassing laboratory delivery, strategic data insights, and dedicated research initiatives. Established in 2008, the company maintains its corporate headquarters in Irving, Texas.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Good
84/100

Analyst Price Target

ⓘ
Average Target
$394.36
▼ −0.9% Downside
High Target$444.64
Low Target$334.78
Based on 21 analysts

Latest News & Updates

🚀
MarketWatch·2h ago

CARIS LIFE SCIENCES INC tops quarterly estimates as demand accelerates

Revenue grew double digits with management guiding above consensus; margins continued to expand.

🛰️
Reuters·5h ago

Analysts lift CAI price targets on improving margins

Several firms raised targets, citing stronger free cash flow and a healthier backlog.

🌌
Bloomberg·1d ago

CARIS LIFE SCIENCES INC announces new agreement to expand its footprint

The move broadens the company’s reach and could add incremental revenue over the next year.